Evidence map›Paper›PMID 23899836›Full record

ArticleMolecules (Basel, Switzerland)2013

Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach.

Lalit N Goswami, Lixin Ma, Peter J Kueffer, Satish S Jalisatgi, M Frederick Hawthorne

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Synthesis of Bis(Carboranyl)amides 1,1'-μ-(CHMolecules (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lalit N GoswamiInternational Institute of Nano and Molecular Medicine, School of Medicine, University of Missouri, Columbia, MO 65211-3450, USA.
Lixin Ma
Peter J Kueffer
Satish S Jalisatgi
M Frederick Hawthorne
University of Missouri · US

Funding

Targetable Exploratory Multinuclear MRI Contrast AgentsR21CA114090 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAWTHORNE, M FREDERICK · 2006 to 2007
$325k
NCI NIH HHS R21 CA114090NCI NIH HHS R21-CA114090
6 · The paper itself

Abstract

An icosahedral closo-B₁₂²⁻ scaffold based nano-sized assembly capable of carrying a high payload of Gd³⁺-chelates in a sterically crowded configuration is developed by employing the azide-alkyne click reaction. The twelve copies of DO3A-t-Bu-ester ligands were covalently attached to an icosahedral closo-B₁₂²⁻ core via suitable linkers through click reaction. This nanomolecular structure supporting a high payload of Gd³⁺-chelate is a new member of the closomer MRI contrast agents that we are currently developing in our laboratory. The per Gd ion relaxivity (r₁) of the newly synthesized MRI contrast agent was obtained in PBS, 2% tween/PBS and bovine calf serum using a 7 Tesla micro MRI instrument and was found to be slightly higher (r₁ = 4.7 in PBS at 25 °C) compared to the clinically used MRI contrast agents Omniscan (r₁ = 4.2 in PBS at 25 °C) and ProHance (r₁ = 3.1 in PBS at 25 °C).

Indexed as

Click ChemistryMagnetic Resonance ImagingAlkynesAzidesChelating AgentsContrast MediaGadoliniumHeterocyclic CompoundsHeterocyclic Compounds, 1-RingLigandsOrganometallic Compounds1,4,7-tris(tert-butylacetate)-1,4,7,10-tetraazacyclododecane esterAlkynesAzidesChelating AgentsContrast MediaGadoliniumgadoteridolHeterocyclic CompoundsHeterocyclic Compounds, 1-RingLigandsOrganometallic Compounds

Identifiers

PMID23899836
PMCPMC6270972
OpenAlexW2011104396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.